The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The mutational spectrum of breast and ovarian tumors from BRCA1 and BRCA2 mutation carriers.
Kara Noelle Maxwell
No relevant relationships to disclose
Daniel De Sloover
No relevant relationships to disclose
Lyndsey Emery
No relevant relationships to disclose
Bradley Wubbenhorst
No relevant relationships to disclose
Kurt P D'Andrea
No relevant relationships to disclose
Jessica Long
No relevant relationships to disclose
Rebecca Mueller
No relevant relationships to disclose
Jacqueline Powers
No relevant relationships to disclose
Jill Stopfer
No relevant relationships to disclose
Michael D Feldman
No relevant relationships to disclose
Susan M. Domchek
No relevant relationships to disclose
Robert Daber
No relevant relationships to disclose
Katherine L. Nathanson
No relevant relationships to disclose